Gainers
- Black Diamond Therapeutic (NASDAQ:BDTX) stock moved upwards by 125.0% to $4.14 during Tuesday's pre-market session. The company's market cap stands at $151.1 million.
- Biodexa Pharmaceuticals (NASDAQ:BDRX) stock rose 21.43% to $0.08. The market value of their outstanding shares is at $1.4 million.
- CalciMedica (NASDAQ:CALC) stock increased by 19.93% to $4.03. The company's market cap stands at $22.8 million.
- Avalo Therapeutics (NASDAQ:AVTX) shares increased by 16.01% to $0.58. The market value of their outstanding shares is at $7.6 million.
- Clearside Biomedical (NASDAQ:CLSD) stock moved upwards by 14.21% to $1.42. The company's market cap stands at $87.3 million.
- GRI Bio (NASDAQ:GRI) stock increased by 11.61% to $5.38. The company's market cap stands at $15.7 million.
Losers
- Adicet Bio (NASDAQ:ACET) shares fell 13.7% to $4.02 during Tuesday's pre-market session. The company's market cap stands at $172.6 million.
- Nemaura Medical (NASDAQ:NMRD) shares declined by 12.93% to $0.64. The company's market cap stands at $18.4 million.
- Trxade Health (NASDAQ:MEDS) shares decreased by 12.9% to $14.25. The market value of their outstanding shares is at $145.5 million.
- Benitec Biopharma (NASDAQ:BNTC) stock fell 11.12% to $0.32. The company's market cap stands at $8.9 million.
- Femasys (NASDAQ:FEMY) shares fell 10.73% to $0.58. The market value of their outstanding shares is at $7.6 million.
- Microbot Medical (NASDAQ:MBOT) shares declined by 10.15% to $3.1. The company's market cap stands at $33.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
AVTXAvalo Therapeutics Inc
$20.193.49%
BDRXBiodexa Pharmaceuticals PLC
$6.401.59%
BDTXBlack Diamond Therapeutics Inc
$2.760.08%
BNTCBenitec Biopharma Inc
$12.96-%
CALCCalciMedica Inc
$4.630.87%
FEMYFemasys Inc
$0.8550-0.01%
GRIGRI Bio Inc
$0.5037-4.40%
MBOTMicrobot Medical Inc
$2.38-%
NMRDNemaura Medical Inc
$0.00010-%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
